Ledger.Open graph →
SEC Form D · filed March 18, 2015

Ovid Therapeutics Inc

Offering
$5.1M
Sold
$5.1M
Exemption
Rule 506(b)
Industry
Other Technology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Jeremy M. Levin · New York, NYExec · DirectorMatthew J. During · New York, NYExec · DirectorMark M. Feldberg · New York, NYDirectorRodney J. Ball · Concord, NCExec · DirectorBill Hubbard · Concord, NCExec · DirectorNeil R. Senturia · La Jolla, CAExec · DirectorBradley Messmer · San Diego, CAExec · DirectorMark M. Feldberg · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗